A detailed history of Gamma Investing LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 32 shares of JANX stock, worth $1,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 25 28.0%
Holding current value
$1,740
Previous $1.05 Million 38.87%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$35.29 - $50.26 $247 - $351
7 Added 28.0%
32 $1.45 Million
Q2 2024

Jul 02, 2024

BUY
$35.12 - $64.78 $245 - $453
7 Added 38.89%
25 $1.05 Million
Q1 2024

Apr 05, 2024

BUY
$7.93 - $49.75 $142 - $895
18 New
18 $678,000

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.27B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.